FINWIRES · TerminalLIVE
FINWIRES

Canadian Economy "Lacks a Vibrant Jobs Market", Says Rosenberg Research

-- There were no big surprises to Canada's latest employment data, with job gains of 14,100 in March, just a tad below the consensus estimate of 15,000, said Rosenberg Research after Friday's Labour Force Survey (LFS).

This recouped but a fraction of the 83,900 plunge in February, the research noted, before adding: "Only if you believe that "flat is the new up" can anyone possibly interpret the data positively, because employment in Canada has virtually stagnated since last June -- a stretch of weakness Canada hasn't seen since late 2020, when people thought the [COVID-19] pandemic would never end."

After the sharp 108,400 hit to full-time employment in February, the research noted, there was a further loss of 1,100 this past month. It says a whole lot that the number of full-time positions is down 40,000 over the past six months -- with a notable labor market shift towards part-time employment, which is up more than 80,000 over this time frame, Rosenberg said, noting the unemployment rate stayed at a "lofty" 6.7%, and the employment-to-population ratio also stagnated at 60.6%.

In terms of the sectors that weighed on the jobs headline, the research noted wholesale/retail trade lost 6,700 jobs and is down in four of the past five months, while hotels/restaurants let go of 10,000 employees and are riding a four-month losing streak. When consumer-facing industries are firing people to this extent, Rosenberg pointed out it definitely knows that Canadian demand is in the "dumpster."

According to the research, what the banks see that the macro bulls don't is an interesting dichotomy, because the financial sector fired a net 11,200 workers in March after paring the staff load by 8,700 in February -- this was the sharpest successive decline since September 2023 and before that, try April 2020.

Suffice it to say that if there is one certainty, it is that the Canadian economy lacks a vibrant jobs market. In fact, "sclerotic" is more like it, it added.

相關文章

Asia

Dizal Pharma將在美國臨床腫瘤學會年會上發表三種藥物的研究成果。

根據週三在上海證券交易所發布的公告顯示,江蘇迪扎爾製藥(SHA:688192)表示,將在美國臨床腫瘤學會(ASCO)年會上公佈其新藥sunvozertinib片劑、golidocitinib膠囊和DZD6008的最新研究成果。 sunvozertinib和DZD6008皆用於治療非小細胞肺癌,而golidocitinib則用於治療T細胞淋巴瘤。研究結果顯示,這些藥物均取得了正面成果,尤其是DZD6008,其具有顯著的抗腫瘤活性且安全性良好。 該生技公司的股價在午盤交易中上漲不到2%。

$SHA:688192
Asia

Critica將於3月季度啟動西澳大利亞稀土計畫範圍界定研究。

根據週三提交給澳洲證券交易所的文件顯示,Critica(ASX:CRI)表示,位於西澳大利亞的Jupiter稀土計畫的初步研究已於今年3月季度正式啟動。 該研究整合了選礦、下游加工、基礎設施和開發假設,旨在確定一個基準開發路徑。 公司計劃在6月季度繼續完成Jupiter專案140個鑽孔的資源升級鑽探工作。此外,該公司還計劃準備並運送20,000公斤散裝樣品進行中試規模處理,以支援持續的最佳化、性能提升和中間精礦的生產。

$ASX:CRI
Asia

北太平洋銀行的收購要約確保了對卡里爾銀行的控制權

北太平洋銀行(東京證券交易所代號:8524)週三在東京證券交易所發佈公告稱,其對Career Bank的股份收購要約已獲成功,持股比例增至88.26%,使Career Bank成為其子公司。 北太平洋銀行此次收購了852,487股Career Bank股份,超過了完成交易所需的最低收購數量。 交易結算將於4月28日開始,屆時Career Bank將正式併入北太平洋銀行的財務報表。 北太平洋銀行計劃啟動相關程序,使Career Bank成為其全資子公司,並將其股票從札幌證券交易所下市。此次收購總成本約為15億日圓。

$TYO:8524